Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acura Pharmaceuticals Inc ACUR

Healthcare Drug Manufacturers - Specialty & Generic
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the... see more

Recent & Breaking News (GREY:ACUR)

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results

Marketwired March 2, 2015

Acura Pharmaceuticals to Host 2014 Financial Results Conference Call on March 3, 2015

Marketwired February 23, 2015

Acura Pharmaceuticals Initiates Clinical Study of Meth-Resistant Nexafed(R) Extended-Release Formulations

Marketwired February 16, 2015

Acura Pharmaceuticals Expands Meth-Resistant Decongestant Line With NEXAFED(R) Sinus Pressure + Pain

Marketwired February 5, 2015

Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize Immediate Release Oxycodone Product Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology

Marketwired January 8, 2015

Acura Pharmaceuticals Acknowledges Distribution of Nexafed(R) by Kmart Pharmacy

Marketwired December 23, 2014

Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations

Marketwired December 8, 2014

Acura Pharmaceuticals Announces Third Quarter 2014 Financial Results

Marketwired November 3, 2014

Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014

Marketwired October 28, 2014

Acura Pharmaceuticals Provides Update on Its Hydrocodone Bitartrate With Acetaminophen Tablets Development

Marketwired October 16, 2014

Acura Pharmaceuticals Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints

Marketwired September 29, 2014

Acura Pharmaceuticals Submits Formal Dispute Resolution Request With FDA Regarding Hydrocodone Bitartrate With Acetaminophen Tablets

Marketwired September 15, 2014

Acura Pharmaceuticals Receives Grant From National Institutes of Health to Fund Limitx(TM) Novel Abuse Deterrent Technology

Marketwired August 27, 2014

Acura Pharmaceuticals Provides Update on FDA Discussions Surrounding Development of Aversion Hydrocodone With Acetaminophen Tablet

Marketwired August 15, 2014

Acura Pharmaceuticals Announces Second Quarter 2014 Financial Results

Marketwired August 4, 2014

Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014

Marketwired July 24, 2014

Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug

Marketwired May 27, 2014

Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.

Marketwired May 21, 2014

Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.

Marketwired May 8, 2014

Acura Pharmaceuticals Announces First Quarter 2014 Financial Results

Marketwired May 5, 2014